Lung Cancer Screening Urged as Experts Warn of Preventable Deaths

Lung cancer can develop undetected for years, and experts are urging greater adherence to screening guidelines, warning that tens of thousands of preventable deaths occur annually due to missed opportunities. While routine screening is a cornerstone for early cancer detection and reducing mortality, current lung cancer screening rates remain low, with only about 15% of eligible Americans undergoing the recommended scans.

Daniel J. Boffa, M.D., chair of the American College of Surgeons Commission on Cancer, stated that lung cancer screening is "one of the most powerful ways" to increase survival rates, potentially reducing the chance of death from the disease by 20%. He noted that the disparity between those eligible for screening and those who actually receive it translates into a substantial number of preventable fatalities each year.

Current Screening Guidelines

The American Cancer Society (ACS) recommends an annual low-dose CT scan for individuals aged 50 to 80 who currently smoke, have a history of smoking, or have a 20 pack-year smoking history. Before undergoing screening, patients are advised to discuss the purpose, procedure, benefits, limitations, and potential harms with their healthcare providers. The ACS also advises against screening for individuals with serious health problems that would limit their lifespan or those who would not seek treatment if cancer were detected.

Lary Robinson, M.D., an oncologist at Moffitt Cancer Center, highlighted that early-stage lung cancer often presents without symptoms. However, common symptoms in those who do experience them include a persistent cough, shortness of breath, or coughing up blood. Unexplained weight loss and neurological symptoms like persistent headaches can also be indicators.

Expanding Screening Eligibility

While one in seven lung cancers affects never-smokers, there are currently no set screening guidelines specifically for this group. However, Boffa indicated that research is actively exploring ways to identify individuals who could benefit from screening, predicting improved guidance for never-smokers within the next one to two years. In the interim, individuals with a direct family history of lung cancer, even without a smoking history, and those in higher-risk demographics such as Asian women, may consider annual screenings.

Boffa also expressed hope for future advancements, envisioning a time when a blood test might precede a confirmatory CT scan, making the screening process more accessible and potentially detecting more cancers earlier.

Understanding the Screening Process

Despite the advances in lung cancer treatment, which have improved survival even in advanced stages, a stigma persists, leading some to avoid diagnosis. Boffa emphasized that screening should not be viewed as a path to a terminal diagnosis, noting that research has significantly changed outcomes for lung cancer patients.

Most screenings identify lung nodules or abnormalities, which are more frequently benign conditions like infections or scars rather than tumors. Approximately one-third of screenings also reveal unrelated health issues, such as hardened arteries or nodules in other parts of the body. Boffa reassured that over 99% of detected nodules are benign and stressed the importance of pre-screening conversations to manage expectations, as findings are often not life-shortening.

The CT scan itself is brief, taking only a couple of minutes, and is not performed in an enclosed space like an MRI, making it generally accessible even for individuals with claustrophobia. Reports typically become available within a few days.

Boffa reiterated that for individuals over 50 with a smoking history, undergoing screening is a critical step in reducing the risk of premature death from lung cancer.